Cibc Private Wealth Group, LLC Ionis Pharmaceuticals Inc Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 30 shares of IONS stock, worth $2,209. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30
Previous 1,125
97.33%
Holding current value
$2,209
Previous $39,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding IONS
# of Institutions
432Shares Held
149MCall Options Held
1.72MPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA16.7MShares$1.23 Billion0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16MShares$1.18 Billion0.4% of portfolio
-
Capital World Investors Los Angeles, CA12.5MShares$924 Million0.08% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$760 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.85MShares$578 Million7.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $10.5B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...